Added to YB: 2026-05-13
Pitch date: 2026-05-11
BEAT [neutral]
HeartBeam, Inc.
Author Info
Company Info
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
Market Cap
$47.7M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.05
P/E
-1.43
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
turnaround
Updates: Heartbeam
BEAT (holding update): FDA-cleared synthesized 12-lead ECG tech. 2 concierge practices announced (ClearCardio Dallas, Atelier Beverly Hills) targeting 150k premium patients in NY/FL/Dallas/SoCal. $500-$1k/yr subscription, 70%+ margin, 3-5mo payback. Need 30k patients for $30M rev = CFP ($21M GP vs $17-19M burn). $10M raise at $0.80 (30% discount), insiders loaded up $905k. Stock at $0.83 ($48M mcap) vs $150M peak. High short interest. 2026 low rev, scaling in 2027. Reimbursement optional near-term but part of long-term strategy. Capital raise complete, funded for 2026.
Read full article (8 min)